These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1647 related articles for article (PubMed ID: 28213330)

  • 1. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic synthetic lethality in cancer therapy.
    Zecchini V; Frezza C
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):723-731. PubMed ID: 27956047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer metabolism in space and time: Beyond the Warburg effect.
    Danhier P; Bański P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance.
    Gallez B; Neveu MA; Danhier P; Jordan BF
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):700-711. PubMed ID: 28088332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
    Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
    Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities.
    Baffy G
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):655-664. PubMed ID: 28088333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial metabolism and energy sensing in tumor progression.
    Iommarini L; Ghelli A; Gasparre G; Porcelli AM
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):582-590. PubMed ID: 28213331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
    Mathupala SP
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy.
    Obre E; Rossignol R
    Int J Biochem Cell Biol; 2015 Feb; 59():167-81. PubMed ID: 25542180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy metabolism in skin cancers: A therapeutic perspective.
    Hosseini M; Kasraian Z; Rezvani HR
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):712-722. PubMed ID: 28161328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
    Gomes AS; Ramos H; Soares J; Saraiva L
    Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From cancer metabolism to new biomarkers and drug targets.
    Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L
    Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 83.